ABINGDON HEALTH PLC

Lockdown-easing in the UK comes with caution with officials urging the use of NHS COVID passes. With the UK Prime Minister and the Chief Executive of UK Health Security Agency alluding to immunity status and antibody testing as important considerations for managing risks, Abingdon Health can see challenges in the UK’s COVID pass system which currently doesn't include neutralising IgG antibody testing. In this article we discuss why antibody tests can fill the gap in antigen test and vaccine only COVID strategies. Confirming the presence of SARS-CoV-2 IgG anti-spike antibodies, which neutralise the virus’ ability to penetrate and infect human cells, is powerful for interpreting an individual’s and a population’s immunity status

With global economies needing to confirm and prove who has produced an immune response to COVID-19, and therefore determine who is safe to move about freely. Abingdon Health and its UK-RTC partners announced AbC-19™ (a SARS-CoV-2 IgG antibody rapid test) is now paired with an easy-to-use mobile app which allows a trained professional to generate an antibody certificate on a person’s smartphone. By leveraging the fact that COVID-19 neutralising antibodies are an important factor in the determination of a person’s immunity status, the flexible and easy-to-use AbC-19™ antibody test solution provides a tool to support the opening of economies and a return to normal life. Click the link at the top to read the full article to learn more.